FR15C0069I1 - - Google Patents

Info

Publication number
FR15C0069I1
FR15C0069I1 FR15C0069C FR15C0069I1 FR 15C0069 I1 FR15C0069 I1 FR 15C0069I1 FR 15C0069 C FR15C0069 C FR 15C0069C FR 15C0069 I1 FR15C0069 I1 FR 15C0069I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33312271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR15C0069(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR0305048A external-priority patent/FR2854074B1/fr
Application filed filed Critical
Publication of FR15C0069I1 publication Critical patent/FR15C0069I1/fr
Application granted granted Critical
Publication of FR15C0069I2 publication Critical patent/FR15C0069I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
FR15C0069C 2003-04-24 2015-10-14 Formulation a usage topique d'ivermectine pour le traitement de conditions dermatologiques Active FR15C0069I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0305048A FR2854074B1 (fr) 2003-04-24 2003-04-24 Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US46899403P 2003-05-09 2003-05-09
PCT/EP2004/004950 WO2004093886A1 (en) 2003-04-24 2004-04-22 Topical formulation of ivermectin for the treatment of dermatological conditions

Publications (2)

Publication Number Publication Date
FR15C0069I1 true FR15C0069I1 (enrdf_load_stackoverflow) 2015-12-04
FR15C0069I2 FR15C0069I2 (fr) 2016-04-22

Family

ID=33312271

Family Applications (1)

Application Number Title Priority Date Filing Date
FR15C0069C Active FR15C0069I2 (fr) 2003-04-24 2015-10-14 Formulation a usage topique d'ivermectine pour le traitement de conditions dermatologiques

Country Status (16)

Country Link
US (6) US7550440B2 (enrdf_load_stackoverflow)
EP (1) EP1620113B1 (enrdf_load_stackoverflow)
JP (2) JP5711867B2 (enrdf_load_stackoverflow)
KR (1) KR101187231B1 (enrdf_load_stackoverflow)
AU (1) AU2004231323C1 (enrdf_load_stackoverflow)
BR (1) BRPI0410503B8 (enrdf_load_stackoverflow)
CA (1) CA2522579C (enrdf_load_stackoverflow)
CY (2) CY1111797T1 (enrdf_load_stackoverflow)
FR (1) FR15C0069I2 (enrdf_load_stackoverflow)
HU (1) HUS1500048I1 (enrdf_load_stackoverflow)
LT (1) LTC1620113I2 (enrdf_load_stackoverflow)
LU (1) LU92915I2 (enrdf_load_stackoverflow)
MX (1) MXPA05011208A (enrdf_load_stackoverflow)
PL (2) PL378932A1 (enrdf_load_stackoverflow)
RU (1) RU2350333C3 (enrdf_load_stackoverflow)
WO (1) WO2004093886A1 (enrdf_load_stackoverflow)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
EP1620113B1 (en) * 2003-04-24 2011-07-13 Galderma S.A. Topical formulation of ivermectin for the treatment of dermatological conditions
WO2004103343A1 (fr) * 2003-05-25 2004-12-02 Yuwan Wang Formulation a liberation prolongee a base de dimethicone
DE602005020912D1 (de) 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
FR2883181B1 (fr) * 2005-03-17 2007-05-18 Galderma Sa Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
FR2886850B1 (fr) * 2005-06-10 2007-10-05 Galderma Sa Composition a base d'une avermectine et de peroxyde de benzoyle notamment pour le traitement de la rosacee
FR2886851B1 (fr) * 2005-06-10 2007-10-05 Galderma Sa Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
FR2886852B1 (fr) * 2005-06-10 2007-11-23 Galderma Sa Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
FR2894823B1 (fr) * 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
FR2900052B1 (fr) 2006-04-19 2011-02-18 Galderma Sa Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
FR2906468B1 (fr) * 2006-09-28 2012-09-21 Galderma Sa Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
EP2091325B1 (en) * 2006-10-12 2014-08-06 Topaz Pharmaceuticals Inc. Shampoo-conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment-resistant strains of lice
FR2907012B1 (fr) 2006-10-12 2012-09-21 Galderma Sa Composition dermatologique comprenant des nanocapsules d'avermectine, son procede de preparation et son utilisation
FR2907013B1 (fr) * 2006-10-12 2012-09-21 Galderma Sa Produits de soin cutane a double compartiment comprenant de l'ivermectine, et leurs utilisations
US8901163B2 (en) * 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
DE102007056424A1 (de) * 2007-11-23 2009-05-28 Neopharmacie Gmbh Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion
JP5694944B2 (ja) * 2008-10-29 2015-04-01 トパズ ファーマシューティカルズ インコーポレイティド エマルション系局所治療用製剤の保存方式
US20120004200A1 (en) * 2008-12-23 2012-01-05 Galderma S.A. Topical pharmaceutical composition containing a water-sensitive active principle
US8642665B2 (en) 2011-12-16 2014-02-04 Conopco, Inc. Environmentally friendly, low whitening compositions
JP5717034B2 (ja) * 2012-08-27 2015-05-13 丸和バイオケミカル株式会社 マクロライド系化合物を含有する土壌線虫防除用薬剤
FR3000397A1 (fr) * 2012-12-31 2014-07-04 Galderma Res & Dev Combinaison de laropiprant et d'ivermectine pour le traitement de la rosacee
CN102872066B (zh) 2012-10-19 2014-07-02 厦门大学 伊维菌素及其衍生物的用途
FR3003761B1 (fr) * 2013-03-29 2016-01-01 Galderma Sa Utilisation d'une lactone macrocyclique pour le traitement d'une infection par un papillomavirus
US9233118B2 (en) * 2013-07-08 2016-01-12 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
MX370957B (es) * 2013-11-29 2020-01-09 Galderma Sa Compuesto de la familia de la avermectina o de la familia de la milbemicina para el tratamiento y/o la prevención de la dermatitis atópica.
CN104706584A (zh) * 2013-12-16 2015-06-17 天津迈迪瑞康生物医药科技有限公司 一种伊维菌素脂肪乳浓缩液、其制备方法及用途
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
FR3026010B1 (fr) 2014-09-18 2016-11-04 Galderma Sa Compositions comprenant un compose de la famille des avermectines et de la doxycycline pour le traitement de la rosacee
WO2016096795A1 (en) * 2014-12-15 2016-06-23 Galderma Sa Compound of the avermectin family for treating and/or preventing inflammatory dermatoses
WO2016096797A1 (en) 2014-12-15 2016-06-23 Galderma Sa Compound of the avermectin family in combination with an other active compound for treating and/or preventing inflammatory dermatoses
EP3362045B1 (en) 2015-10-13 2019-10-09 Galderma S.A. A process for preparing a composition comprising a high concentration of one or more avermectins
WO2017064205A1 (en) 2015-10-13 2017-04-20 Galderma Sa A process for preparing a stable emulsion comprising one or more avermectins
EP3493795A1 (en) * 2016-08-04 2019-06-12 Nestlé Skin Health SA Compositions and the use thereof for treating or preventing rosacea
US11160780B2 (en) * 2016-09-30 2021-11-02 Aurobindo Pharma Ltd. Pharmaceutical composition of ivermectin and process for preparation thereof
US11234959B2 (en) 2016-11-03 2022-02-01 Galderma Holding SA Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema
EP3326608A1 (en) 2016-11-24 2018-05-30 Nestlé Skin Health SA Composition comprising avermectin compounds without solid fatty substances
EP3326609A1 (en) 2016-11-24 2018-05-30 Nestlé Skin Health SA Composition comprising avermectin compounds without gelling agents
EP3326614A1 (en) 2016-11-24 2018-05-30 Nestlé Skin Health SA Composition comprising avermectin compounds without solvents and propenetrating agents of avermectin compounds
DK3638251T3 (da) * 2017-06-12 2024-05-13 Lakewood Amedex Inc Bisphosphocin gel formuleringer og brug deraf
CN111655241B (zh) 2017-12-15 2024-10-15 塔苏斯制药有限公司 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法
EP3856145A1 (en) * 2018-09-28 2021-08-04 Galderma Research & Development Pharmaceutical composition in the form of a water-in-oil emulsion (w/o) and its uses
US11312922B2 (en) 2019-04-12 2022-04-26 Ecolab Usa Inc. Antimicrobial multi-purpose cleaner comprising a sulfonic acid-containing surfactant and methods of making and using the same
US12161752B2 (en) 2019-08-20 2024-12-10 Vishwanath Padmanabhan Compositions and methods for the treatment of anterior blepharitis and posterior blepharitis
CN115379824A (zh) * 2019-08-21 2022-11-22 生物制药股份有限公司 用于局部递送活性剂的溶剂递送系统
KR20220052474A (ko) 2020-10-21 2022-04-28 순천향대학교 산학협력단 주사증 진단을 위한 마이크로RNA-21-3p 및 이의 용도
KR102480430B1 (ko) 2020-10-21 2022-12-21 순천향대학교 산학협력단 주사증 진단을 위한 마이크로RNA-31-5p 및 이의 용도
US11291679B1 (en) * 2021-03-22 2022-04-05 Mountain Valley Md Inc. Injectable, infusable, instillable ivermectin adjuvant for cancer therapies
EP4062907A1 (fr) 2021-03-23 2022-09-28 Substipharm Formulation par voie orale d'ivermectine et utilisations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
GB9422306D0 (en) * 1994-11-04 1994-12-21 Sandoz Ltd Organic compounds
US5952371A (en) * 1996-10-16 1999-09-14 Merck & Co., Inc. Triterpene derivatives with immunosuppressant activity
RU2138268C1 (ru) * 1997-09-22 1999-09-27 Мосин Владимир Александрович Средство, подавляющее пролиферацию и вызывающее гибель опухолевых клеток, при этом защищающее нормальные клетки
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6310968B1 (en) * 1998-11-24 2001-10-30 Picker International, Inc. Source-assisted attenuation correction for emission computed tomography
AU781703B2 (en) * 1999-01-25 2005-06-09 Blue Ridge Pharmaceuticals, Inc. Liposome formulations
US6133310A (en) * 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6399652B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
US20030064940A1 (en) * 2001-10-02 2003-04-03 Parks L. Dean Kit for treating acne vulgaris using avermectin compound
US6399651B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US6319945B1 (en) * 2000-06-29 2001-11-20 L. Dean Parks Method of treatment of seborrheic dermatitis
DE10063946A1 (de) * 2000-12-20 2002-07-04 Basf Ag Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 2,2'-p-Phenylen-bis(3,1-benzoxazin-4-on) enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
EP1476121A4 (en) * 2002-02-08 2010-10-27 Merck Sharp & Dohme TOPICAL IVERMECTIN COMPOSITION
EP1480633A2 (en) * 2002-03-04 2004-12-01 Divergence, Inc. Nematicidal fatty acid and fatty acid ester related compounds
EP1620113B1 (en) * 2003-04-24 2011-07-13 Galderma S.A. Topical formulation of ivermectin for the treatment of dermatological conditions
FR2867684B1 (fr) 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
DE602005020912D1 (de) * 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme

Also Published As

Publication number Publication date
US20120258062A1 (en) 2012-10-11
BRPI0410503B8 (pt) 2021-05-25
BRPI0410503B1 (pt) 2018-07-10
US20120077766A1 (en) 2012-03-29
WO2004093886A1 (en) 2004-11-04
FR15C0069I2 (fr) 2016-04-22
US8598129B2 (en) 2013-12-03
JP5711867B2 (ja) 2015-05-07
PL1620113T3 (pl) 2011-10-31
JP2006524212A (ja) 2006-10-26
RU2005136438A (ru) 2006-05-27
JP5538461B2 (ja) 2014-07-02
CA2522579C (en) 2012-08-28
US8093219B2 (en) 2012-01-10
US8415311B2 (en) 2013-04-09
AU2004231323A1 (en) 2004-11-04
EP1620113A1 (en) 2006-02-01
HUS1500048I1 (hu) 2017-10-30
AU2004231323B2 (en) 2009-12-10
US20060100165A1 (en) 2006-05-11
US7550440B2 (en) 2009-06-23
CA2522579A1 (en) 2004-11-04
CY2016031I1 (el) 2017-03-15
JP2012126738A (ja) 2012-07-05
KR20060004667A (ko) 2006-01-12
LU92915I2 (fr) 2016-02-17
US8470788B2 (en) 2013-06-25
US20130209381A1 (en) 2013-08-15
KR101187231B1 (ko) 2012-10-02
BRPI0410503A (pt) 2006-06-20
EP1620113B1 (en) 2011-07-13
RU2350333C2 (ru) 2009-03-27
CY1111797T1 (el) 2015-10-07
PL378932A1 (pl) 2006-06-12
RU2350333C3 (ru) 2018-08-24
US8080530B2 (en) 2011-12-20
MXPA05011208A (es) 2005-12-14
LTC1620113I2 (lt) 2018-02-26
US20090252797A1 (en) 2009-10-08
US20090227668A1 (en) 2009-09-10
AU2004231323C1 (en) 2016-11-03
CY2016031I2 (el) 2017-03-15

Similar Documents

Publication Publication Date Title
BE2013C075I2 (enrdf_load_stackoverflow)
BE2013C070I2 (enrdf_load_stackoverflow)
BE2013C067I2 (enrdf_load_stackoverflow)
BE2013C038I2 (enrdf_load_stackoverflow)
BE2013C036I2 (enrdf_load_stackoverflow)
BE2011C030I2 (enrdf_load_stackoverflow)
BE2013C034I2 (enrdf_load_stackoverflow)
BE2012C053I2 (enrdf_load_stackoverflow)
AU2002329412A1 (enrdf_load_stackoverflow)
AU2002339901A1 (enrdf_load_stackoverflow)
AU2002255066A1 (enrdf_load_stackoverflow)
AU2002256398A1 (enrdf_load_stackoverflow)
AU2002310561A1 (enrdf_load_stackoverflow)
AU2002311957A1 (enrdf_load_stackoverflow)
AU2002316235A1 (enrdf_load_stackoverflow)
AU2002316511A1 (enrdf_load_stackoverflow)
AU2002318342A1 (enrdf_load_stackoverflow)
AU2002321535A1 (enrdf_load_stackoverflow)
AU2002322913A1 (enrdf_load_stackoverflow)
AU2002324323A1 (enrdf_load_stackoverflow)
AU2002327042A1 (enrdf_load_stackoverflow)
AU2002327736A1 (enrdf_load_stackoverflow)
AU2002253451A1 (enrdf_load_stackoverflow)
AU2002331433A1 (enrdf_load_stackoverflow)
AU2002332887A1 (enrdf_load_stackoverflow)